145 related articles for article (PubMed ID: 37929351)
1. Partner of NOB1 homolog transcriptionally activated by E2F transcription factor 1 promotes the malignant progression and inhibits ferroptosis of pancreatic cancer.
Yang Q; Yang B; Chen M
Chin J Physiol; 2023; 66(5):388-399. PubMed ID: 37929351
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of PNO1 inhibits esophageal cancer progression.
Wang G; Li Q; Li C; Duan G; Sang H; Dong H; Yang Y; Ma C; Tao T
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33864661
[TBL] [Abstract][Full Text] [Related]
3. Upstream stimulatory factor 2 inhibits erastin-induced ferroptosis in pancreatic cancer through transcriptional regulation of pyruvate kinase M2.
Chen M; Li X; Du B; Chen S; Li Y
Biochem Pharmacol; 2022 Nov; 205():115255. PubMed ID: 36210578
[TBL] [Abstract][Full Text] [Related]
4. PNO1 promotes the progression of osteosarcoma via TGF-β and YAP/TAZ pathway.
Fang L; Wang B; Yang Z; Zhao T; Hao W
Sci Rep; 2023 Dec; 13(1):21827. PubMed ID: 38071381
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor ETV1-induced lncRNA MAFG-AS1 promotes migration, invasion, and epithelial-mesenchymal transition of pancreatic cancer cells by recruiting IGF2BP2 to stabilize ETV1 expression.
Weng H; Feng W; Li F; Huang D; Lin L; Wang Z
Growth Factors; 2023 Aug; 41(3):152-164. PubMed ID: 37428861
[TBL] [Abstract][Full Text] [Related]
6. PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancer.
Peng YP; Zhu Y; Yin LD; Zhang JJ; Wei JS; Liu X; Liu XC; Gao WT; Jiang KR; Miao Y
J Exp Clin Cancer Res; 2017 Feb; 36(1):30. PubMed ID: 28193232
[TBL] [Abstract][Full Text] [Related]
7. Ribosome assembly factor PNO1 is associated with progression and promotes tumorigenesis in triple‑negative breast cancer.
Li J; Liu L; Chen Y; Wu M; Lin X; Shen Z; Cheng Y; Chen X; Weygant N; Wu X; Wei L; Sferra TJ; Han Y; Chen X; Shen A; Shen A; Peng J
Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35445733
[TBL] [Abstract][Full Text] [Related]
8. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
Yan R; Liang ZW; Liu HS; Ge Y; An GY
Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
[No Abstract] [Full Text] [Related]
9. E2F transcription factors promote tumorigenicity in pancreatic ductal adenocarcinoma.
Bertonnier-Brouty L; Andersson J; Kaprio T; Hagström J; Bsharat S; Asplund O; Hatem G; Haglund C; Seppänen H; Prasad RB; Artner I
Cancer Med; 2024 May; 13(9):e7187. PubMed ID: 38686617
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
11. [
Zhang RH; Huang JP; Li JW; Li YQ; Cui XY; Xiong YN; Liu YK; Zhang GL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):558-564. PubMed ID: 37248584
[TBL] [Abstract][Full Text] [Related]
12. HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation.
Chang J; Hu X; Nan J; Zhang X; Jin X
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34558641
[TBL] [Abstract][Full Text] [Related]
13. Blocking the E2F transcription factor 1/high-mobility group box 2 pathway enhances the intervention effects of α-santalol on the malignant behaviors of liver cancer cells.
Wang H; Tang M; Pei E; Shen Y; Wang A; Lin M
Int J Biochem Cell Biol; 2024 Mar; 168():106516. PubMed ID: 38219975
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ZNF488 supports pancreatic cancer cell proliferation and tumorigenesis through inhibition of ferroptosis via regulating SCD1-mediated unsaturated fatty acid metabolism.
Xiao Q; Lan Z; Zhang S; Ren H; Wang S; Wang P; Feng L; Li D; Wang C; Bai X; Zhang J
Biol Direct; 2023 Nov; 18(1):77. PubMed ID: 37986084
[TBL] [Abstract][Full Text] [Related]
15. LINC02086 inhibits ferroptosis and promotes malignant phenotypes of pancreatic cancer via miR-342-3p/CA9 axis.
Xiong Y; Kong X; Tu S; Xin W; Wei Y; Yi S; Wan R; Xiao W
Funct Integr Genomics; 2024 Mar; 24(2):49. PubMed ID: 38438595
[TBL] [Abstract][Full Text] [Related]
16. E2F1-mediated up-regulation of TOP2A promotes viability, migration, and invasion, and inhibits apoptosis of gastric cancer cells.
Chen YU; Yu Y; Lv M; Shi Q; Li X
J Biosci; 2022; 47():. PubMed ID: 36550695
[TBL] [Abstract][Full Text] [Related]
17. CISD2 transcriptional activated by transcription factor E2F7 promotes the malignant progression of cervical cancer.
Wang L; Wang Y; Wang C; Yang K; Ye G
J Mol Histol; 2023 Oct; 54(5):489-498. PubMed ID: 37615745
[TBL] [Abstract][Full Text] [Related]
18. hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223.
Zhang X; Tan P; Zhuang Y; Du L
Am J Physiol Gastrointest Liver Physiol; 2020 Dec; 319(6):G703-G717. PubMed ID: 32878470
[TBL] [Abstract][Full Text] [Related]
19. MYC-mediated upregulation of PNO1 promotes glioma tumorigenesis by activating THBS1/FAK/Akt signaling.
Chen X; Guo ZQ; Cao D; Chen Y; Chen J
Cell Death Dis; 2021 Mar; 12(3):244. PubMed ID: 33664245
[TBL] [Abstract][Full Text] [Related]
20. The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma.
Ma L; Tian X; Wang F; Zhang Z; Du C; Xie X; Kornmann M; Yang Y
Cancer Biol Ther; 2016 Oct; 17(10):1051-1061. PubMed ID: 27573434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
